Mutant p53 (p53mut) proteins gain new capabilities including dominant negative effects over the remaining wild-type p53 (p53wt), wild-type p63, and wild-type p73 tumor suppressor proteins, as well as gain-of-function effects promoting cancer aggressiveness and resistance to therapies (3). The gene discussed is TP53; the disease is cancer.